CDK6 and hepatocellular carcinoma: Quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis demonstrated that CDK6 mRNA was upregulated in lenvatinib-resistant HCC cells, while its level was decreased upon treatment with U0126 and CA3 (Fig. 5f).